Pay in 4 interest-free payments of $7.45 Learn more
Ships within 48 hours · Estimated delivery Jul 31 - Aug 5
In adults with type 2 diabetes and obesity, the top dose cut weight up to an average of 20.8% at 80 weeks, with A1C down up to an average of 1.6% (efficacy estimand)
Our complex contains 400 mg of silymarin per daily dose
Ozempic was first approved in 2017 by the US Food and Drug Administration (FDA) as an injectable drug to help "lower blood sugar levels in adults with type 2 diabetes mellitus, in addition to diet and exercise." Wegovy was approved the same year to help adults and children aged 12 years and older, who were overweight or living with obesity
Participants with existing hypertension experienced weight loss and often required fewer blood pressure medications as their health improved, demonstrating that tirzepatide can be both safe and beneficial for this population
According to the company: ColonBroom advises against use of ColonBroom GLP-1 Booster if you have mood disorders, liver or kidney disease, or are pregnant or breastfeeding
It replenishes nutrients essential for metabolic function and cellular energy
